VA
Valneva SE
VALN · NASDAQ
$6.56 +0.15% (+$0.01)
1M -2.81%
Market Cap 541.7M €
P/E Ratio -
Div. Yield -
ROE 152.63%
Piotroski F-Score Weak
1/9Valuation
32 /100
Expensive P/B 6.68x
P/S 3.77x
PEG N/A
Growth
0 /100
Declining Book val. growth 21.54%
Rev. growth 21.52%
FCF growth N/A
Profitability
4 /100
Weak FCF margin 59.70%
Op. margin 80.93%
Gross margin 16.35%
Quality
5 /100
Poor Asset turnover 0.37x
ROA 40.75%
ROIC 37.97%
Debt
23 /100
High Current ratio 2.16x
Int. coverage -2.83x
Debt/Equity 2.59x
Stability
16 /100
Unstable Profitable years 0
EPS volatility 428.59%
Beta 1.35x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o VALN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas Lingelbach
Employees
674
Headquarters
Saint-Herblain
Nadchodzące wydarzenia
19 LIS
Earnings
Upcoming earnings report